NDC 69339-160-01 - Megestrol Acetate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 69339-160
- Requested NDC
- 69339-160-01
- Package NDCs from labels
- 69339-160-01, 69339-160-16, 69339-160-17, 69339-160-18, 69339-160-19
- Manufacturer
- Natco Pharma USA LLC | Strides Pharma, Inc
- Effective date
- 2026-01-15
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Megestrol Acetate - Natco Pharma USA LLC | Strides Pharma, Inc | Natco Pharma USA LLC | Strides Pharma, Inc | 2026-01-15 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69339-160-01 | Megestrol Acetate | 10 mL in 1 CUP, UNIT-DOSE | SUSPENSION | 10 | 2 | |
| 69339-160-16 | Megestrol Acetate | 3 in 1 CASE | SUSPENSION | 3 | 2 | |
| 69339-160-16 | Megestrol Acetate | 10 in 1 TRAY | SUSPENSION | 10 | 2 | |
| 69339-160-17 | Megestrol Acetate | 4 in 1 CASE | SUSPENSION | 4 | 2 | |
| 69339-160-17 | Megestrol Acetate | 10 in 1 TRAY | SUSPENSION | 10 | 2 | |
| 69339-160-18 | Megestrol Acetate | 10 in 1 TRAY | SUSPENSION | 10 | 2 | |
| 69339-160-18 | Megestrol Acetate | 5 in 1 CASE | SUSPENSION | 5 | 2 | |
| 69339-160-19 | Megestrol Acetate | 10 in 1 CASE | SUSPENSION | 10 | 2 | |
| 69339-160-19 | Megestrol Acetate | 10 in 1 TRAY | SUSPENSION | 10 | 2 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 69339-160-01 | ML - Milliliter | 69339-160 | 67edb6da-5e2c-4fcc-8a4a-3b098aaff6eb | 1 | 2023-09-05 |
| 69339-160-16 | ML - Milliliter | 69339-160 | 27f6e6c7-08d3-442e-b959-3a663f185453 | 1 | 2023-09-05 |
| 69339-160-17 | ML - Milliliter | 69339-160 | 31b3dcc7-2913-4c24-b3a6-640158ec6c37 | 1 | 2023-09-05 |
| 69339-160-18 | ML - Milliliter | 69339-160 | 59fcc138-63c5-45d5-b946-93f453f55056 | 1 | 2023-09-05 |
| 69339-160-19 | ML - Milliliter | 69339-160 | da7e552a-6eec-4c7f-993b-b3d609d66d99 | 1 | 2023-09-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Docusate Sodium | DOCUSATE SODIUM | NuCare Pharmaceuticals,Inc. | 56f7966a-c95e-3ce3-e054-00144ff88e88 | 2024-08-14 | Warnings | F05Q2T2JA0 |
| Sool Softener Laxative | DOCUSATE SODIUM, SENNOSIDES | EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC) | 7104b955-fadd-4ce7-9342-fb28027fc4a9 | 2024-08-12 | Warnings | F05Q2T2JA0 |
| Senna S Orange | DOCUSATE SODIUM SENNOSIDES | Care One (Retail Business Services, LLC.) | 3da76cb2-08c3-475d-9320-69450bbcf8cd | 2024-08-09 | Warnings | F05Q2T2JA0 |
| Senna Plus | DOCUSATE SODIUM, SENNOSIDES | AmerisourceBergen (Good Neighbor Pharmacy) 46122 | 68bf0d90-db4b-48f0-bce1-80127922bc82 | 2024-08-09 | Warnings | F05Q2T2JA0 |
| Senna S | DOCUSATE SODIUM, SENNOSIDES | United Natural Foods, Inc. dba UNFI | 3f519d42-72bc-4cc3-a43f-14b94a10eb9a | 2024-08-09 | Warnings | F05Q2T2JA0 |
| Stool Softener plus Laxative | DOCUSATE SODIUM, SENNOSIDES | QUALITY CHOICE (Chain Drug Marketing Association) | ebb35e67-4e83-445e-af6e-ecb43b1d3df6 | 2024-08-09 | Warnings | F05Q2T2JA0 |
| Senna S | DOCUSATE SODIUM, SENNOSIDES | TOP CARE (Topco Associates LLC) | 3984f4aa-2794-410c-ae9e-ee5bc31c0470 | 2024-08-09 | Warnings | F05Q2T2JA0 |
| Up and Up Hemorrhoid MAX STRENGTH | 14.4% GLYCERIN, 0.25% PHENYLEPHRINE HCL, 1% PRAMOXINE HCL, 15% PETROLATUM | Target Corporation | 867677b5-fd1d-449e-966e-1de0b5c98afb | 2024-08-08 | Warnings | PDC6A3C0OX |
| Stool Softener Laxative | DOCUSATE SODIUM AND SENNOSIDES | WinCo Foods, LLC | 2776d463-753d-4fee-ab5e-210ce3604411 | 2024-08-07 | Warnings | F05Q2T2JA0 |
| Stool Softener with laxative | DOCUSATE SODIUM AND SENNOSIDES | WinCo Foods, LLC | 3803830c-187d-4403-9606-db036418386f | 2024-08-07 | Warnings | F05Q2T2JA0 |
| Stool Softener Laxative | DOCUSATE SODIUM | Proficient Rx LP | ccfa095c-77f0-41ff-84f8-e02d983c7c74 | 2024-08-01 | Warnings | F05Q2T2JA0 |
| Stool Softener | DOCUSATE SODIUM SENNOSIDES | QUALITY CHOICE (Chain Drug Marketing Association) | d4128fbd-32ba-4d2e-ae1a-cbe438f5b39b | 2024-07-31 | Warnings | F05Q2T2JA0 |
| Stool Softener Laxative Plus Stimulant | DOCUSATE SODIUM AND SENNOSIDES | Walgreens | db528659-768a-46e0-a340-9fbcdb25ea5e | 2024-07-25 | Warnings | F05Q2T2JA0 |
| Stimulant Laxative Plus Stool Softener | DOCUSATE SODIUM AND SENNOSIDES | GOOD SENSE | 17cdef7b-71bf-b4a6-e063-6294a90a5b74 | 2024-07-22 | Warnings | F05Q2T2JA0 |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID MONOHYDRATE | American Health Packaging | 58fa9952-c8ab-4ebb-a073-15cc45f4832a | 2024-07-16 | Adverse reactions | 1Q73Q2JULR |
| Stool Softener | DOCUSATE SODIUM AND SENNOSIDES | Strategic Sourcing Services LLC | b23e53d4-fd7d-452d-a851-35a143b6dcb4 | 2024-07-08 | Warnings | F05Q2T2JA0 |
| Zenibell Snail IntensiveCream | GLYCERIN | MISOCOS | 97c19dca-237c-c968-e053-2a95a90aeae7 | 2024-07-05 | Warnings | PDC6A3C0OX |
| Zenibell Snail Intensive Toner | GLYCERIN | MISOCOS | 97c1b556-824d-bef7-e053-2a95a90ae1f2 | 2024-07-05 | Warnings | PDC6A3C0OX |
| aewajin Derma Hydrocell | GLYCERIN | MISOCOS | 980fcaea-27ba-da49-e053-2995a90ad506 | 2024-07-05 | Warnings | PDC6A3C0OX |
| aewajin Derma Hydrocell 24k Gold Serum | GLYCERIN | MISOCOS | a17b2c6e-9db8-bae4-e053-2a95a90adcf6 | 2024-07-05 | Warnings | PDC6A3C0OX |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.